LongeVC | Latest News & Updates - Jan 22, 2025 Release

LongeVC's portfolio company Melio, led by Mridu Sinha, received a $3.5M grant to develop a platform for rapid identification of bloodstream infections, starting with neonatal sepsis...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


LongeVC

🌎 longevc.com

LongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage biotech and longevity-focused founders, helping them gain industrial momentum, raise capital, and shape the future of the biotech industry. LongeVC aims to build a broad community of biotech innovators by funding companies in complementary sectors and facilitating collaboration among them.


LongeVC - Latest News and Updates

  • LongeVC's portfolio company Melio, led by Mridu Sinha, received a $3.5M grant to develop a platform for rapid identification of bloodstream infections, starting with neonatal sepsis.
  • Rubedo Life Sciences, a portfolio company of LongeVC, announced plans for a Phase 1 clinical trial of their GPX4 modulator RLS-1496 targeting aging cells.
  • LongeVC will participate as a sponsor in the Longevity Science Summit in Miami, aiming to raise $250K for longevity research projects.
  • LongeVC's co-founders Sergey Jakimov and Ilya Suharenko will participate in the Unicorn Summit in Lisbon, Portugal from June 29 to July 2, 2025.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.